Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy

World J Surg Oncol. 2023 Sep 15;21(1):291. doi: 10.1186/s12957-023-03179-3.

Abstract

This report describes the case of a 70-year-old man with metastatic squamous cell carcinoma (SCC) of the right lower leg. Soon after definitive surgical management of the primary and nodal metastases with curative intent, he relapsed, developing aggressive in-transit metastatic disease and recurrent nodal disease. The patient was treated with systemic immunotherapy alone, which not only prompted the progressive nodal metastases to regress, but also resulted in a complete response of the in-transit disease. This situation is previously undescribed in the medical literature.

Keywords: Anti-PD-1; Immunotherapy; In-transit; In-transit metastases; Squamous cell carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Squamous Cell* / drug therapy
  • Carcinoma, Squamous Cell* / surgery
  • Humans
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Immunotherapy
  • Male
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / surgery

Substances

  • Immune Checkpoint Inhibitors